Netazepide

Netazepide has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Nov 9, 2025: “Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosis”.

Intervention

1 paper studies it6 findingsUpdated

PubChem

See all 1 papers on netazepide

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“We found that gastrin increased by 90% in response to GRA as early as 7 d (p-value for treatment: .0008)”
Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosisJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2025doi:10.1093/jbmr/zjaf165

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 6 of 6 findings with company ties
  • Human trial1

Studies in people

1 study gave netazepide to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on CTX

up: Increases gastrin+90%

down: Decreases pepsinogen I-15%

Randomized trial90 d99 peoplewomenmean age of 60 yrPostmenopausal womenJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Nov 9, 2025

What did studies of netazepide find?

3

Studies of netazepide measured 3 outcomes: pepsinogen I, gastrin and CTX.

Pepsinogen I

downin humans1−15%

1 study
  1. Netazepide decreases pepsinogen I in humans (-15%).

    Human trial90 dfemalesn = 99

  2. Netazepide decreases pepsinogen I in humans (-15% (p = .0002)).

    Human trial100 mg daily90 dfemalesn = 99

More on Pepsinogen I

Gastrin

upin humans1+90%

1 study
  1. Netazepide increases gastrin in humans (+90%).

    Human trial90 dfemalesn = 99

  2. Netazepide increases gastrin in humans (+90% (p = .0008)).

    Human trial100 mg daily90 dfemalesn = 99

More on Gastrin

CTX

no changein humans1

1 study
  1. Netazepide showed no clear effect on CTX in humans.

    Human trial90 dfemalesn = 99

  2. Netazepide showed no clear effect on CTX in humans (no significant change).

    Human trial100 mg daily90 dfemalesn = 99

More on CTX

Latest